Annual report pursuant to Section 13 and 15(d)

EQUITY (Details 2)

v3.21.2
EQUITY (Details 2) - $ / shares
 12 Months Ended
Aug. 31, 2021
Aug. 31, 2020
Aug. 31, 2019
EQUITY      
Number of Options Outstanding 281,834,000 234,000,000 50,000,000
Number of shares granted during period 2,755,100,000 74,000,000 184,000,000
Number of Options Exercised 0 0  
Number of Options Forfeited/canceled (177,750,000) (26,166,000)  
Number of Options Outstanding 2,859,184,000 281,834,000 234,000,000
Number of Options Outstanding, Exercisable 292,666,000    
Weighted Average Exercise Price, Outstanding $ 3.57 $ 3.88 $ 10.80
Weighted Average Exercise Price, Granted 2.28 2.48  
Weighted Average Exercise Price, Exercised 0 0  
Weighted Average Exercise Price, Forfeited/canceled (2.57) 3.31  
Weighted Average Exercise Price, Outstanding 2.39 $ 3.57 $ 3.88
Weighted Average Exercise Price, Exercisable $ 3.29    
Weighted Average Remaining Contractual life (in years), Beginning 9.78 9.78 P9Y9M11D
Weighted Average Remaining Contractual life (in years), Granted 10.00 10.00  
Weighted Average Remaining Contractual life (in years), Forfeited/canceled 8.33 9.58  
Weighted Average Remaining Contractual life (in years), Ending 9.27 8.90  
Weighted Average Remaining Contractual life (in years), Exercisable options 7.75